New studies and regulatory warnings raise questions Recent research and regulatory actions have added nuance to the safety profile of GLP 1 receptor agonists, the class of drugs widely used for diabetes and weight loss. Scientific presentations have reported …
Recent research and regulatory actions have added nuance to the safety profile of GLP-1 receptor agonists, the class of drugs widely used for diabetes and weight loss. Scientific presentations have r… [+1780 chars]
